Larvol Delta - AVM-Biotechnology-Announces-TwentyEight-28-Solid-Tumor-and-Blood-Cancer-Patients-have-been-Treated-with-Immunomodulatory-AVM0703-through-Expanded-AccessCompassionate-Use-Programs

dexamethasone sodium phosphate (AVM0703) - AVM Biotechnology

https://www.businesswire.com/news/home/20230731194052/en/AVM-Biotechnology-Announces-Twenty-Eight-28-Solid-Tumor-and-Blood-Cancer-Patients-have-been-Treated-with-Immunomodulatory-AVM0703-through-Expanded-AccessCompassionate-Use-Programs

Aug 1, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next